1 2 3 4 5 6 7 8 9 10 11 12 13 14
далее локализованными и небольшими опухолями почки. БИБЛИОГРАФИЧЕСКИЙ СПИСОК 1. Bostwick DC, Murphy GP. Diagnosis and prognosis of renal cell carcinoma: highlights from an international consensus workgroup. Sem Urol Oncol 1998; 16: 46-52 2. Аль-Шукри СХ, Ткачук ВН. Опухоли мочеполовых органов. СПб.: Питер, 2000; 60-78 3. Возианов АФ, Романенко AM, Сайдакова НА и др. Экологический патоморфоз почечноклеточного рака в загрязненных радионуклидами регионах Украины. Жури АМН Украины 2002; (1): 120-131 4. Brkovic D, Riedash G, StaehlerQ. UrologeA 1997; 36 (2): 103-108 5. Hafez KS.Novick AC, Campbell SC. Ibid 1997; 157 (4): 2067-2070 6. Klein EA, Novick AC. Comprehensive textbook of genitourinary oncology. Baltimore, 1996; 207-217 7. Lerner SE, Hawkinks CA, Blute ML et al. Parthial nephrectomy. J Urol 1996; 155 (2): 61-66 8. Степанов ВН, Колпаков ИС, Серегин АВ. Материалы 3-й Всероссийской научн. конф. «Консервативная хирургия при опухоли почки» сучастием стран СНГ. М., 1999; 151158 9. Kovacs G, Akhtar М, Beckwith ВН. The Heidelberg classification of renal cell tumors. J Pathol 1999; 183: 131-135 10. Kovacs G. Molecular genetics and diagnosis of renal cell tumors. Urologe A 1999; 38: 433-441 11. Delahunt B. Histopathologic prognostic indicators for renal cell carcinoma. Semin Diagn Pathol 1998; 15: 68-76 12. Fuhrman SA, Lasky LS, Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 19S2; 6:655-663 13. Hemmerlein В, Markus A, Wehner M et al. Expression of acute and late-stage inflammatory antigens, c-fms, CSF-1, and human monocytic serine esterase 1, in tumor-associatedmacrophages of renal cell carcinomas. Cancer Immuriol Immunother 2000; 49 (9): 485-492 14. Kowalczyk D, Skorupski W, Kwias Z, Nowak J. Flow cytometric analysis of tumour-infiltrating lymphocytes in patients with renal cell carcinoma. Cancer Immunol Immunother 2001; 53(5): 543-548 15. Shabtai M, Ye H, Frischer Z et al. Increased expression of activation markers in renal cell carcinoma infiltrating lymphocytes. J Urol 2002; 168 (5): 2216-2219 16. Zolota V, Tsamandas AC, Melachrinou M et al. Expression of CD44 protein in renal cell carcinomas: association with p53 expression. Urol Oncol 2002; 7(1): 13-17 17. Huang J, Soffer SZ, Kim ES et al. p53 accumulation in favorable-histology Wilms tumor is associated with angiogenesis and clinically aggressive disease. J Pediatr Surg 2002;37(3): 523-527 18. Yoshioka K, Nakamura S.Chromosome 9 and 17 aberrations and p53 gene deletion detected by fluorescence in situ hybridization in renal-cell carcinoma. Mol Urol 2001; 5 (1): 11-17 19. Hashimoto H, Sue Y, Saga Y et al. Roles of p53 and MDM2 in tumor proliferation and determination of the prognosis of transitional cell carcinoma of the renal pelvis and ureter. Int J Urol 2000; 7(12): 457-463 20. Rioux-Leclercq N, Turlin В, Bansard J et al. Value of immunohistochemical Ki-67 and p53 determinations as predictive factors of outcome in renal cell carcinoma. Urology 200 далее ...